-
Something wrong with this record ?
Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate
P. Melenovská, J. Kopecká, J. Krijt, A. Hnízda, K. Raková, M. Janošík, B. Wilcken, V. Kožich,
Language English Country Netherlands
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 1999-02-01 to 2018-11-30
Medline Complete (EBSCOhost)
from 2009-08-01 to 1 year ago
Health & Medicine (ProQuest)
from 1999-02-01 to 2018-11-30
- MeSH
- Arginine pharmacology MeSH
- CHO Cells MeSH
- Cricetulus MeSH
- Cystathionine beta-Synthase genetics metabolism MeSH
- Phenotype MeSH
- Fibroblasts drug effects enzymology MeSH
- Genetic Predisposition to Disease MeSH
- Heme pharmacology MeSH
- Homocystinuria diagnosis drug therapy enzymology genetics MeSH
- Homozygote MeSH
- Catalytic Domain MeSH
- Protein Conformation MeSH
- Humans MeSH
- Molecular Chaperones pharmacology MeSH
- Models, Molecular MeSH
- Mutation * MeSH
- Proteostasis Deficiencies diagnosis drug therapy enzymology genetics MeSH
- Protein Folding MeSH
- Substrate Specificity MeSH
- Transfection MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
Classical homocystinuria is caused by mutations in the cystathionine β-synthase (CBS) gene. Previous experiments in bacterial and yeast cells showed that many mutant CBS enzymes misfold and that chemical chaperones enable proper folding of a number of mutations. In the present study, we tested the extent of misfolding of 27 CBS mutations previously tested in E. coli under the more folding-permissive conditions of mammalian CHO-K1 cells and the ability of chaperones to rescue the conformation of these mutations. Expression of mutations in mammalian cells increased the median activity 16-fold and the amount of tetramers 3.2-fold compared with expression in bacteria. Subsequently, we tested the responses of seven selected mutations to three compounds with chaperone-like activity. Aminooxyacetic acid and 4-phenylbutyric acid exhibited only a weak effect. In contrast, heme arginate substantially increased the formation of mutant CBS protein tetramers (up to sixfold) and rescued catalytic activity (up to ninefold) of five out of seven mutations (p.A114V, p.K102N, p.R125Q, p.R266K, and p.R369C). The greatest effect of heme arginate was observed for the mutation p.R125Q, which is non-responsive to in vivo treatment with vitamin B(6). Moreover, the heme responsiveness of the p.R125Q mutation was confirmed in fibroblasts derived from a patient homozygous for this genetic variant. Based on these data, we propose that a distinct group of heme-responsive CBS mutations may exist and that the heme pocket of CBS may become an important target for designing novel therapies for homocystinuria.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010716
- 003
- CZ-PrNML
- 005
- 20161104074400.0
- 007
- ta
- 008
- 160408s2015 ne f 000 0|engg|
- 009
- AR
- 024 7_
- $a 10.1007/s10545-014-9781-9 $2 doi
- 024 7_
- $a 10.1007/s10545-014-9781-9 $2 doi
- 035 __
- $a (PubMed)25331909
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Melenovská, Petra $u Institute of Inherited Metabolic Disorders, Charles University in Prague-First Faculty of Medicine and General University Hospital in Prague, Ke Karlovu 2, 128 08, Praha 2, Czech Republic.
- 245 10
- $a Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate / $c P. Melenovská, J. Kopecká, J. Krijt, A. Hnízda, K. Raková, M. Janošík, B. Wilcken, V. Kožich,
- 520 9_
- $a Classical homocystinuria is caused by mutations in the cystathionine β-synthase (CBS) gene. Previous experiments in bacterial and yeast cells showed that many mutant CBS enzymes misfold and that chemical chaperones enable proper folding of a number of mutations. In the present study, we tested the extent of misfolding of 27 CBS mutations previously tested in E. coli under the more folding-permissive conditions of mammalian CHO-K1 cells and the ability of chaperones to rescue the conformation of these mutations. Expression of mutations in mammalian cells increased the median activity 16-fold and the amount of tetramers 3.2-fold compared with expression in bacteria. Subsequently, we tested the responses of seven selected mutations to three compounds with chaperone-like activity. Aminooxyacetic acid and 4-phenylbutyric acid exhibited only a weak effect. In contrast, heme arginate substantially increased the formation of mutant CBS protein tetramers (up to sixfold) and rescued catalytic activity (up to ninefold) of five out of seven mutations (p.A114V, p.K102N, p.R125Q, p.R266K, and p.R369C). The greatest effect of heme arginate was observed for the mutation p.R125Q, which is non-responsive to in vivo treatment with vitamin B(6). Moreover, the heme responsiveness of the p.R125Q mutation was confirmed in fibroblasts derived from a patient homozygous for this genetic variant. Based on these data, we propose that a distinct group of heme-responsive CBS mutations may exist and that the heme pocket of CBS may become an important target for designing novel therapies for homocystinuria.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a arginin $x farmakologie $7 D001120
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a cystathionin-beta-synthasa $x genetika $x metabolismus $7 D003541
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibroblasty $x účinky léků $x enzymologie $7 D005347
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a hem $x farmakologie $7 D006418
- 650 _2
- $a homocystinurie $x diagnóza $x farmakoterapie $x enzymologie $x genetika $7 D006712
- 650 _2
- $a homozygot $7 D006720
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární chaperony $x farmakologie $7 D018832
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a sbalování proteinů $7 D017510
- 650 _2
- $a poruchy proteostázy $x diagnóza $x farmakoterapie $x enzymologie $x genetika $7 D057165
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a substrátová specifita $7 D013379
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kopecká, Jana
- 700 1_
- $a Krijt, Jakub
- 700 1_
- $a Hnízda, Aleš $7 xx0207773
- 700 1_
- $a Raková, Kateřina
- 700 1_
- $a Janošík, Miroslav
- 700 1_
- $a Wilcken, Bridget
- 700 1_
- $a Kožich, Viktor
- 773 0_
- $w MED00002747 $t Journal of inherited metabolic disease $x 1573-2665 $g Roč. 38, č. 2 (2015), s. 287-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25331909 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20161104074329 $b ABA008
- 999 __
- $a ok $b bmc $g 1114145 $s 935084
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 38 $c 2 $d 287-94 $e 20141021 $i 1573-2665 $m Journal of inherited metabolic disease $n J Inherit Metab Dis $x MED00002747
- LZP __
- $a Pubmed-20160408